3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
15
HER2-positive Breast Cancer
4
Carcinoma, Non-Small-Cell Lung
2
Triple Negative Breast Neoplasms
1
Salivary Gland Neoplasms
1
Non-squamous NSCLC
1
Non Small Cell Lung
1
Lung Neoplasms
1
Locally Advanced Breast Cancer
1
HER2-positive Early Breast Cancer
1
HER2-Positive, Unresectable and/or Metastatic Breast Cancer Subjects Previously Treated With Trastuzumab and Taxane
1
Breast Cancer Invasive
1
Breast Cancer Female
1
Advanced Digestive System Tumor
1
Advanced Breast Cancer
1
Interventions
pyrotinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced Breast Cancer
×
pyrotinib
×
1 year
×
Clear all
NCT04254263
2025-09-11
ATP
RenJi Hospital
Phase 3
Recruiting
316 enrolled